ABSTRACT: We completed a systematic literature review of in vivo animal models that use arthrotomy-based methods to study particle-induced peri-implant osteolysis. The purpose of the review was to characterize the models developed to date, to determine the questions addressed, to assess scientific rigor and transparency, and to identify gaps in knowledge. We probed three literature databases (Medline, Embase, and Scopus) and found 77 manuscripts that fit the search parameters. In the most recent 10 years, researchers mainly used rat and mouse models, whereas in the previous 20 years, large animal, canine, and rabbit models were more common. The studies have demonstrated several pathophysiology pathways, including macrophage migration, particle phagocytosis, increased local production of cytokines and lysosomal enzymes, elevated bone resorption, and suppressed bone formation. The effect of variation in particle characteristics and concentration received limited attention with somewhat mixed findings. Particle contamination by endotoxin was shown to exacerbate peri-implant osteolysis. The possibility of early diagnosis was demonstrated through imaging and biomarker approaches. Several studies showed that both local and systemic delivery of bisphosphonates inhibits the development of particle-induced osteolysis. Other methods of inhibiting osteolysis include the use of anabolic agents and altering the implant design. Few studies examined non-surgical rescue of loosened implants, with conflicting results with alendronate. We found that the manuscripts often lacked the methodological detail now advocated by the ARRIVE guidelines, suggesting that improvement in reporting would be useful to maximize rigor and transparency. ß
The number of primary total joint replacement (TJR) surgeries is projected to grow considerably in the coming decades leading to increasing numbers of patients requiring revision surgery. Aseptic loosening and mechanical instability are the two main mechanisms of failure in primary TJR, 1 with particle-induced osteolysis widely accepted as a key factor in aseptic loosening. [2] [3] [4] [5] [6] [7] [8] [9] In addition, there are other factors that contribute to instability and primary implant failure such as peri-implant fracture 10 or peri-implant bone loss due to stress-shielding and infection. [11] [12] [13] Regardless of the cause for primary implant failure, the only treatment for a loosened implant is revision surgery. Indeed, it is estimated that by 2030 over 350,000 patients in the United States will need revision surgery due to implant failure.
14 While newer generation materials may lessen the burden of revision surgery in the future, there are still a large number of patients who are likely to experience particle-induced osteolysis over the next few decades.
A better understanding of the pathophysiology and improved ability to diagnose the condition early may lead to novel methods of preventing or rescuing particle-induced osteolysis. The concept of particleinduced inflammation leading to osteolysis was first proposed after examination of human tissues retrieved during revision surgery in the 1970s. 2, 8 Periimplant tissue necrosis, repair, and bone remodeling were noted 2 ; it was hypothesized that the cellular response to particles caused implant loosening due to loss of peri-implant bone. 8 This original hypothesis, as proposed by the German orthopedic surgeon, Hans Willert, emphasized the importance of multiple tissues in the peri-implant environment, including the joint capsule.
Researchers soon began using laboratory models to understand the pathophysiology of particle-induced osteolysis with the long-term goal of preventing implant loosening or even rescuing loosened implants without performing revision surgery. To this end, researchers have developed and used a variety of in vitro and in vivo models. In vitro studies showed that particle size, shape, surface area, volume, and composition affect the biological response. 15, 16 Other in vitro studies were important in pointing out potential biological pathways involved such as the inflammasome 5, 15 and the inflammatory response elicited when macrophages phagocytose particles. [17] [18] [19] Because of the inherent limitations of in vitro models, and the noted involvement of multiple tissues, researchers developed in vivo models to investigate the local and systemic biological response to particleinduced osteolysis. There are four commonly used in vivo models to study particle-induced osteolysis, including air pouch, 20, 21 calvarial, 22, 23 metaphyseal, 24 and arthrotomy-based models. 25 The air pouch model is often used to study bone resorption in the presence of particles 21 and the inflammatory response to particles. 26 The calvarial model is frequently used to study molecular mechanisms of osteolysis as well as to test inhibition of bone resorption in the presence of particles. 23, 27 The air pouch and calvarial models lack an implant and exposure to the synovial cavity; two key elements present in the human joint replacement.
Metaphyseal models are used to study bone-implant osseointegration and, in some cases, implant fixation, but rarely in the presence of particles. 28 Metaphyseal models, whether or not an implant is included, still lack exposure to the synovial cavity.
In this systematic review, we focus on in vivo animal models that use arthrotomy-based methods to place implants and include administration or generation of particulate debris as a challenge. Our viewpoint is that studies utilizing this experimental approach will provide the most direct translational relevance to the human condition of osteolysis because of the inclusion of all of the tissues mentioned in the original Willert hypothesis. For instance, it is clear that particles change the morphology of the synovium from a thin, pliable membrane to a thickened, particle-laden membrane. [29] [30] [31] [32] The synovial membrane also expresses inflammatory cytokines when exposed to particles. 32 It is important to recognize that no preclinical model replicates all aspects of the human disease under investigation and that the advantages and disadvantages of each model type need to be assessed in the context of the research question being asked. 33, 34 The purpose of the review is to characterize the arthrotomy-based models developed to date, to determine the questions addressed, to assess rigor and transparency in the studies, and to identify gaps in knowledge. To our knowledge, a systematic review of particle-induced osteolysis in this preclinical model has not previously been performed. In conducting the review, we found it useful to organize the findings according to species used, experimental outcomes examined, research questions addressed, and completeness of reporting.
SEARCH STRATEGY AND CRITERIA
To ensure an unbiased review of the literature, we took a systematic approach using the PRISMA guidelines. 35, 36 We utilized three databases: MEDLINE (Pubmed), Embase, and Scopus. The Embase search engine includes Embase Classic, which searches back to 1947. MEDLINE (PubMed) searches back to 1946 and Scopus includes material other than manuscripts such as patents, book chapters, and conference abstracts dating back to 1970. The search strategy used text words, keywords, and MeSH search terms to complete as broad a search as possible ( Table 1) .
The search was completed on April 19, 2016 and yielded 729 manuscripts in MEDLINE as accessed through Pubmed, 1,524 manuscripts in Embase, and 228 in Scopus for a total of 2,481 potential manuscripts for abstract review (Fig. 1 ). Of these manuscripts, 863 were duplicated across the databases and were eliminated prior to abstract review, leaving 1,618 unique manuscripts for initial review. The abstracts of all 1,618 manuscripts were assessed. The criteria used to include manuscripts for full review were the presence of an implant placed through an arthrotomy, the use of a non-human in vivo animal model, a challenge with particles, the paper was written in English, and peer-reviewed.
Using these criteria, 1,595 manuscripts were eliminated for the following reasons:
No implant: Forty manuscripts were removed that tested the biological response to particles in the absence of an implant. Route of implant placement: Fifty-four manuscripts were removed that utilized implants not placed through a joint. No particles: Sixty-two manuscripts were removed that focused on implant loosening due to factors not including particles. Human studies: Nine-hundred sixty-four manuscripts were removed that focused on patient populations, case studies, human/cadaver tissues, and clinical trials. Other in vivo osteolysis models: Sixty manuscripts were removed that used the rodent calvarial model (48) or the air pouch model (12) . Non-English manuscripts: Forty-four manuscripts were removed due to being published in languages other than English. Miscellaneous: Three-hundred seventy-one manuscripts were removed that related to the spine (17), fractures (4), review articles (186), published abstracts (3), and in vitro models (161).
Thus, 23 manuscripts from the initial search were selected for full review. In addition, hand searches based on the literature cited sections of the 23 manuscripts and newly discovered manuscripts from manual database searches were performed and yielded 54 additional articles that met the inclusion criteria. One of the additional manuscripts post-dates the date of the original data base interrogation. 37 In total, 77 articles were analyzed in this systematic review ( Fig. 1) .
Analysis of the these 77 manuscripts was used to construct a database in which each article was classified according to (i) animal species by model characteristics and endpoints analyzed (experimental design); (ii) main research aim(s) of the study (research questions); and (iii) adherence of the Methods sections to the published ARRIVE guidelines. 38 
RESULTS

Experimental Design
We first analyzed the experimental design reported in all 77 articles that met the inclusion criteria ( Table 2 ). All manuscripts reviewed here used one of six model species (canine, sheep, goat, rabbit, rat, or mouse). In the most recent 10 years of research, the use of mice increased and the use of rats remained more or less constant, while the use of canine, sheep, goat, and rabbit models decreased (Fig. 2) . The models were classified as weight-bearing (n ¼ 38) or non-weightbearing (n ¼ 39). The majority of the weight-bearing implants were studied in larger bodied species, while non-weight-bearing implants tended to be studied in rabbits and rodents. Nearly all of the surgical sites had access to the synovial cavity (n ¼ 74), while in three studies, the surgical site was sealed from the synovial cavity. The continuity between implant site and the joint provides access for intra-articularly placed particles to migrate along the implant surface. The most commonly studied particles were polyethylene (PE, n ¼ 52), followed by titanium (Ti, n ¼ 12), polymethylmethacrylate (PMMA, n ¼ 11), cobalt-chrome (CoCr, n ¼ 2), a combination of these materials (n ¼ 3), or other miscellaneous particles (n ¼ 5). All of the studies were then further categorized according to the endpoints reported.
For experimental endpoints, we first considered those that were analogous to clinical diagnostic methods such as whole bone radiography, behavior (e.g., evidence of pain), or biomarkers. We found that 15 papers reported on whole bone radiography, including variables such as radiolucencies at the bone-implant interface. There was only one paper that measured behavior, as a surrogate for pain assessment. 39 Six papers examined biomarkers with four focusing on blood, urine or synovial fluid 32, [39] [40] [41] and two using imaging biomarkers. 42, 43 Ultimately, good implant function requires secure fixation with surrounding bone and thus, many of the in vivo animal models included a measurement of implant fixation strength, usually from push-out or pull-out mechanical tests. Implant fixation strength acted as a surrogate for implant loosening. Sixteen of the 77 reviewed studies included this endpoint.
Many endpoints were used to investigate underlying mechanisms driving particle-induced osteolysis. Here, we organized these endpoints by biological hierarchy starting with bone surrounding the implant. Peri-implant bone volume (n ¼ 24) and bone-implant contact (n ¼ 18) were the most frequently examined endpoints. Of these 42 measurements, nine used ex vivo microcomputed tomography (mCT), eight used in vivo mCT, four used dual energy X-ray absorptiometry, 17 used histology, and two used backscatter scanning electron microscopy (bSEM) or SEM. Static and/or dynamic histomorphometry were measured in 11 of the 77 reviewed studies which is relevant to the proximate cause of implant loosening, altered bone remodeling. Peri-implant histology was by far the most common endpoint for studying cellular composition and overall tissue changes adjacent to the implant and was prevalent across all six species (n ¼ 64 studies). Histology of the joint capsule as an endpoint was examined in only nine studies. Some endpoints, such as histomorphometry and histology, are destructive and preclude the study of other endpoints on the same specimens. This is something to consider during the experimental design process.
Investigators have also focused on locally expressed proteins and enzymes. For instance, immunohistochemistry for proteins associated with inflammation, bone formation, or bone remodeling was commonly completed in rabbit, rat, and mouse samples (n ¼ 15 studies). Tartrate-resistant alkaline phosphate staining for osteoclasts tended to be completed in rabbit, rat, and mouse models (n ¼ 14 studies), but there were far fewer studies that specifically attempted to identify osteoblasts (e.g., by alkaline phosphatase staining, n ¼ 2 studies).
In order to further investigate the underlying mechanisms of osteolysis, cell and tissue culture assays using retrieved tissues (n ¼ 12 studies) and peri-implant gene and protein expression (n ¼ 8 studies) have also been examined. Flow cytometry was used in two studies to determine the type of cells present in PARTICLE-INDUCED OSTEOLYSIS SYSTEMATIC REVIEW circulation following particle challenge. The use of molecular markers as endpoints is relatively new in the field and was mostly completed in rabbits and rodents.
Research Questions
The main questions posed in the 77 articles reviewed were grouped into six broad research aims (Table 3) . These aims included model development, pathophysiology, effect of particle characteristics or concentration, role of endotoxin, early diagnosis (biomarkers), and treatment.
In model development (n ¼ 26 studies), the primary aim was to establish a model showing one or more translational endpoints related to peri-implant bone loss and/or implant loosening (loss of mechanical fixation). These endpoints included evidence of implant loosening, 25 Thus, most authors would consider their model validated if it met one or more of these endpoints.
Pathophysiology was the primary focus in 25 articles and focused on cellular responses to particle challenge. 55, 66, 73, 81, 100 It was shown that administration of particles elevates the inflammatory response and bone resorption in peri-implant tissues. 31, 92 In the presence of particles, macrophages migrated 37, 106 ; foreign body giant cells and macrophages phagocytosed particles 80 ; and cytokine, 108 lysosomal enzyme, 68 and prostaglandin E 2 levels 67 increased. The role of cytokines in the inflammatory cascade was reported to be complex and multi-factorial. 105 As a continuation of this cell signaling cascade, osteoclast activity and bone resorption were escalated, 65 which causes peri-implant bone loss and implant loosening. One study found an uncoupling of osteoblast and osteoclast activity in the peri-implant region, leading to the formation of a bony rim. 50 The decrease in bone formation and increase in bone resorption noted in peri-implant bone were reflected in serum bone turnover markers. 39, 40 The effect of particle material composition, shape, and concentration was studied in six articles, with three focused on shape characteristics. 72, 89, 98 One Note that a few articles focused on multiple research aims and therefore are listed multiple times.
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study tested the effects of two sizes of PE particles 59 and another study tested the size effects of different particle materials on histiocyte reaction. 92 It was shown that polycarbonate-urethane particles allowed for better implant fixation than ultra-high molecular weight polyethylene particles, which led to less boneimplant contact. 89 The treatment of particles with barium sulphate induced bone resorption. 72 There was one study that found that PE particles alone do not initiate peri-implant bone resorption. 98 One study tested the effects of particle concentration and showed that development of a gap surrounding the implant increased as particle concentration increased. 70 The role of endotoxin contamination, specifically lipopolysaccharide (LPS), was discussed in three articles. LPS contamination of particles, either by incubating the particles in LPS-containing solution or by administering LPS via intraperitoneal injection, was shown to exacerbate peri-implant osteolysis. 89, 96, 99 Early diagnosis was assessed in two studies; one used a macromolecular bioimaging approach 42 and one used a bone turnover biomarker. 39 Both studies showed that early detection of osteolysis is feasible in highly controlled preclinical animal models.
Studies that focused on treatment were divided into three categories: prevention (n ¼ 23), rescue (n ¼ 2), and revision (n ¼ 5). In the prevention studies, an agent was administered at or close to the initiation of the particle challenge. In the rescue studies, an agent was administered only after the osteolytic phenotype developed. With regard to prevention, many studies found that bisphosphonates, administered systemically 51, 52, 73, 83, 87, 88, 90, 99 or locally, 32, 83, 9732, 83, 97 inhibit the development of particle-induced osteolysis. Other anti-resorption strategies included gene transfer therapy targeting resorption promoting signals decreased particle-induced osteolysis. 76, 83, 109 Anti-inflammatory approaches also inhibited development of osteolysis. 37, 74, 76, 86 Anabolic agents, such as intermittent parathyroid hormone (PTH) 94 and sclerostin antibody, 95 also inhibit the development of particle-induced osteolysis. A number of studies showed that osteolysis can be inhibited through implant design, mainly by altering the characteristics of the implant surface, 32, 37, 63, 64, 74, 97 although two studies indicated that this approach was not effective. 81, 82 Thus, both local 32, 37, 63, 64, 74, 76, 78, 83, 97, 109 and systemic 51, 52, 73, 83, [86] [87] [88] 90, 94, 95, 99 approaches have shown merit. Only two studies investigated the rescue of failed implants. Both examined alendronate with one finding positive results 73 and one finding negative results with no treatment effect. 62 Finally, there are several reports that fixation of revision implants can be enhanced by allograft, 41, 60 growth factor soaked allograft, 49 hydroxyapatite/tricalcium phosphate bone graft substitute, 44 or autogenous bone graft. 44 
Reporting of ARRIVE Guidelines
The ARRIVE guidelines were published in 2010 to enhance the reporting of in vivo biomedical research designs and results. 38 For each manuscript, we assessed the experimental design in terms of compliance to these guidelines, using the Journal of Orthopedic Research ARRIVE checklist, which was adapted from the checklist provided by the National Centre for the Replacement, Refinement and Reduction of Animals in Research website (https://www.nc3rs.org.uk/ arrive-guidelines). There are nine items listed in the Methods section of the ARRIVE guidelines. Three of these items were relatively well-described in the majority of the reviewed papers, including the ethical statement, the overall study design, and some aspects of experimental animal information. Five items were consistently poorly described, including experimental procedures, sample size, allocation of animals to experimental group, specific experimental outcomes, and statistical methods. One item was rarely reported (housing and husbandry). Specific sub-items that were rarely or never reported included some of the specific experimental procedure details, explanation of animal allocation, and reason for the number of animals and clearly defined primary and secondary study outcomes. Surprisingly, we found little difference in completeness of reporting in the 65 papers published prior to and the 12 papers published after the guidelines were published in 2010.
DISCUSSION
In this systematic review, 77 published articles were selected using five main criteria, which included the presence of an arthrotomy-placed implant, the use of a non-human in vivo animal model, a challenge with particles, English as the publication language, and peer-reviewed. Less than one-third of these articles were found using specific search terms to probe literature databases, while two-thirds of the articles were found via hand searches completed outside of the original search. Our purpose was to discover the composition of literature on in vivo particle-induced osteolysis, focusing on model development, the questions researchers have addressed, rigor and transparency, and identification of gaps in knowledge. From the reviewed literature, the research questions addressed were grouped into five categories, including model development, characterization of pathophysiology, effect of particle properties, role of endotoxins, early diagnosis, and treatment. It is clear that arthrotomy-based in vivo animal models provide environments in which peri-implant osteolysis can be studied with translationally relevant outcomes.
The use of preclinical models in research is critical and attempts to mimic, in a short amount of time, a series of events that may take years to occur in humans. There are a whole host of patient, surgeon, and implant factors 110, 111 that are not necessarily replicated in preclinical models. Indeed, the value of models is to eliminate as many of the confounding factors as possible to develop a clearer picture of how variation in the factor being studied affects the outcome measure of interest. It is important to recognize this advantage of preclinical models, but also to recognize that the models are often not useful for answering the types of questions addressed in clinical studies (e.g., survivorship, pain, patient satisfaction). The use of animal models in research has shifted from larger animals to small rodent models often because of the specific questions being asked. We recommend that authors justify the particular model used in their experiments in terms of the questions addressed in the study. Overall, small animal models are more useful for questions about molecular pathways and mechanisms, while larger animals are often more useful for translational questions. In addition, species-specific differences in bone structure such as trabecular architecture or the prevalence of Haversian systems and the histology of the peri-articular soft tissues may be informative about the proper species to use.
The studies reviewed here showed that osteolysis, specifically assessed through measurement of the loss of peri-implant bone and/or implant fixation, can be prevented by using bisphosphonates, but the ability to rescue loosened implants has not been demonstrated. While bisphosphonates have several benefits such as decreasing bone loss and promoting fracture healing, 112 long-term use of bisphosphonates has been associated with untoward events such as atypical femoral fracture. 113 Thus, the rationale for using bisphosphates for improving survival of joint replacement requires careful consideration.
No attempt has been made to rescue loosened implants in the animal models outside of the use of bisphosphonates, which as just noted, met with inconsistent results. The feasibility of rescuing a loose implant would probably requires the conversion of a peri-implant membrane to bone at the implant interface. While this conversion has not been examined in the context of particle-induced osteolysis, there is one experiment in which a formerly loose implant was stabilized via the use of a hydroxyapatite coating. 114 To our knowledge, the possibility of rescuing a loose implant with an anabolic agent has not been examined in an animal model, although intermittent PTH treatment has been reported in two clinical case studies to improve implant fixation. 115, 116 Other areas of research that could use more study include the role of the synovium and discovery of biomarkers. Willert and Semlitsch explicitly stressed the importance of the joint capsule and synovium in osteolysis 40 years ago. Interestingly, the examination of the synovium and/or pseudo-joint capsule using histology or any other methodology has been largely ignored as an endpoint. 8 The identification of cell types in peri-implant tissues is also poorly documented, although cell type could point to pathophysiological mechanisms involved in the progression of osteolysis. There is a need for a non-invasive, early diagnostic tool for osteolysis. Biomarker analysis may be one such tool that should be pursued in synovial fluid, blood, or urine as well as novel imaging approaches. It is possible that behavioral testing may be an early marker of implant loosening, but this endpoint is rarely studied in animal models. Early diagnostic tests could help monitor disease progression, allow for early treatment and ultimately delay or eliminate revision surgery in humans.
Recently, the National Institutes of Health (NIH) posted an online notice on enhancing reproducibility through rigor and transparency for conducting research (https://grants.nih.gov/grants/guide/notice-files/ NOT-OD-15-103.html). Although this policy is aimed at NIH grant applications and progress reports, it would be beneficial to apply it to publications as well. We used the ARRIVE guidelines as a tool to assess the rigor and transparency of published reporting of experimental details. These guidelines include many of the criteria highlighted in NOT-OD-15-103. From our review, it is clear that the existence of the ARRIVE guidelines has not yet altered the amount of detail reported in the literature, though guidelines such as these are critical to the success and reproducibility of future biomedical research.
There are many factors that can affect study outcomes, including species or strain used, surgical approach, and the housing environment. 117 Layer these factors onto a simplified, imperfect in vivo animal model compared to their human clinical counterpart and the complexity of outcome interpretation increases. As the guidelines become compulsory in more journals, it is possible that experimental details will be reported more completely in the future. We believe that better reporting of methodological details will accelerate the pace of discovery and help address the gaps in knowledge more efficiently.
CONCLUSION
We conducted a systematic review to characterize arthrotomy-based models of particle-induced peri-implant osteolysis to determine the questions addressed with these models, to assess rigor and transparency in the studies, and to identify gaps in knowledge. The reviewed animal model studies have shown that pharmacologic agents and implant design can inhibit the development of particle-induced osteolysis. Only some of these findings have been translated to the clinic. It is less certain if loosened implants can be rescued non-surgically. An improved understanding of pathophysiology and the development of better tools for early diagnosis are clear areas of need and can be expected to lead to translational benefits. Improvements in reporting experimental details and careful consideration of experimental models would likely accelerate progress.
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